Skip to Content

LE HR (Letrozole 2.5 mg)

Pill with imprint LE HR is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Jiangsu Hengrui Pharmaceutical Co., Ltd..

Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LE HR

Letrozole

Imprint:
LE HR
Strength:
2.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Aromatase inhibitors
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Jiangsu Hengrui Pharmaceutical Co., Ltd.
National Drug Code (NDC):
57884-2021

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide